Bdl. Li et al., QUANTIFYING C-MYC EXPRESSION IN C-MYC ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE-TREATED LEUKEMIC AND COLON-CANCER CELL-LINES, The Journal of surgical research, 59(4), 1995, pp. 485-492
Antisense oligodeoxynucleotides (oligo) have been used to inhibit onco
gene expression and have potential therapeutic applications. Using a 1
5-mer antisense phosphorothioate oligo (S-oligo), inhibition of c-myc
oncogene expression and cellular proliferation is studied in two cell
Lines with c-myc overexpression: a colon cancer cell line (Cole 320 DM
) and a promyelocytic leukemic cell line (HL-60). Quantitative analysi
s of c-myc mRNA transcript is performed by competitive reverse transcr
iption-polymerase chain reaction (RT-PCR). This utilizes an RNA compet
itive reference standard (CRS RNA) template that is identical to the n
ative c-myc mRNA except for a short segment deletion to allow for diff
erentiation of the two by gel electrophoresis. A fixed quantity of tes
t mRNA and a series of known concentrations of CRS RNA template placed
in the same test tubes under identical conditions are reverse transcr
ibed and amplified by PCR. Since the reaction is competitive, the rati
o of the PCR products reflects the ratio of the initial concentrations
of the two templates. After gel electrophoresis, the two PCR products
are quantified densitometrically. Treating Cole 320 DM and HL-60 cell
s with c-myc antisense oligo and S-oligo results in a 20- to 100-fold
decrease in c-myc mRNA transcripts, respectively. This inhibition is d
ose dependent and sequence specific (c-myc sense and missense oligo ha
ve no effects). The quantitative decrease in c-myc mRNA is associated
with corresponding inhibition of c-myc oncoprotein synthesis as demons
trated by how cytometry and Western blots. Furthermore, there is inhib
ition of cellular proliferation of the respective cell lines. Thus tre
ating two cell lines with known c-myc overexpression with c-myc antise
nse S-oligo results in: (1) a decrease in c-myc mRNA transcripts, (2)
a decrease in c-myc oncoprotein synthesis, and (3) an inhibition of ce
llular proliferation. (C) 1995 Academic Press, Inc.